Patents by Inventor Markus Kurz

Markus Kurz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160214846
    Abstract: A valve block assembly for a bottle attachment apparatus for handling liquids has a valve block, an intake valve insert and/or an exhaust valve insert, and a valve receptacle assigned to the respective valve insert. The valve insert is inserted in a replaceable and sealing manner in the valve receptacle. The valve insert has a stop portion, a fastening portion distinct therefrom and a sealing portion distinct from both. The associated valve receptacle has stop, fastening, and sealing portions matching the equivalent portions of the valve insert. When the valve insert is installed correctly both the stop portions and the sealing portions bear on one another in a planar manner.
    Type: Application
    Filed: January 21, 2016
    Publication date: July 28, 2016
    Applicant: BRAND GMBH + CO KG
    Inventors: Günter Hochholzer, Markus Kurz
  • Publication number: 20150159158
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 11, 2015
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Patent number: 8946184
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: February 3, 2015
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Publication number: 20130237589
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: March 4, 2013
    Publication date: September 12, 2013
    Applicant: ARCHEMIX LLC
    Inventors: Claude BENEDICT, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Patent number: 8436164
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 7, 2013
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Patent number: 8362234
    Abstract: The present invention relates to a compound according to the formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, Y, Z, n, s, and t are as defined herein. These compounds are useful for methods of solid phase synthesis.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: January 29, 2013
    Inventors: Paul J. Hatala, Markus Kurz
  • Publication number: 20120322860
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 20, 2012
    Applicant: ARCHEMIX LLC
    Inventors: CLAUDE BENEDICT, DAVID EPSTEIN, CHARLES WILSON, DILARA MCCAULEY, JEFFREY KURZ, MARKUS KURZ, THOMAS GREENE MCCAULEY, JAMES ROTTMAN
  • Patent number: 8236773
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: August 7, 2012
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Patent number: 7803931
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: September 28, 2010
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Chesworth Keene, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna J. Zoltoski
  • Patent number: 7790421
    Abstract: Described herein are methods and reagents for the ligation of a peptide acceptor to an RNA, as well as the RNA-peptide acceptor products.
    Type: Grant
    Filed: July 10, 2006
    Date of Patent: September 7, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Markus Kurz, Peter Lohse, Richard W. Wagner
  • Publication number: 20100041866
    Abstract: A compound which can be attached to a solid support and used as a reagent for methods of solid phase synthesis has the following structure: (I) where Ri is selected from hydrogen and C1-C6 alkyl; R2 is selected from hydrogen, hydroxy, and C1-C6 alkoxy, or together R1 and R2 form a single bond; R3, R4, R5 and R6 are the same or different from each other and each represents hydrogen, C1-C6 alkyl, and halogen, or together R3 and R4 with R5 and R6 form an aromatic ring, further wherein the aromatic ring is substituted with one or more X; X is selected from halogen, nitro, amino, and aminocarbonyl; s is 0, 1, 2, or 3, t is 0, 1, 2, or 3, wherein s+t?1; R7 and R8 are the same or different from each other and each represents hydroxy, halogen, hydrogen, C1-C6 alkoxy, oxyacyl, or together R7 and R8 form a carbonyl; Y is selected from a methylene or substituted methylene, nucleoside, nucleotide, protected nucleoside, protected nucleotide, C1-C6 aryl, arylalkyl, heteroalkyl, heterocycle, and heteroaryl; n is 1, 2, 3, 4,
    Type: Application
    Filed: March 26, 2007
    Publication date: February 18, 2010
    Applicant: ARCHEMIX CORP.
    Inventors: Paul J. Hatala, Markus Kurz
  • Patent number: 7579450
    Abstract: The invention discloses aptamers capable of binding to Immunoglobulin E (“IgE”) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: August 25, 2009
    Assignee: Archemix Corp.
    Inventors: Paula Burmeister, Sharon Cload, John L. Diener, Anthony Dominic Keefe, Sara Chesworth Keene, Markus Kurz, H. A. Daniel Lagassé, Harold Nicholas Marsh, Pooja Sawhney, Chunhua Wang
  • Patent number: 7579456
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: August 25, 2009
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, David Epstein, Dilârâ McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Charles Wilson
  • Patent number: 7538211
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: May 26, 2009
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Chesworth Keene, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna J. Zoltoski
  • Publication number: 20080051299
    Abstract: Disclosed herein are molecules that include a deoxyribonucleic acid (DNA) covalently bonded to a protein and uses thereof.
    Type: Application
    Filed: March 22, 2007
    Publication date: February 28, 2008
    Inventors: Peter Lohse, Markus Kurz
  • Patent number: 7195880
    Abstract: Disclosed herein are molecules that include a deoxyribonucleic acid (DNA) covalently bonded to a protein and uses thereof.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: March 27, 2007
    Assignee: Adnexus Therapeutics, Inc.
    Inventors: Peter Lohse, Markus Kurz
  • Publication number: 20070066551
    Abstract: The invention relates generally to the field of nucleic acids and more particularly to aptamers useful as therapeutics, diagnostics and in research such as for target validation. The invention further relates to materials and methods for enhancing aptamers for use in therapeutics, diagnostics and research.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 22, 2007
    Inventors: Anthony Keefe, Charles Wilson, John Diener, Markus Kurz
  • Publication number: 20070048248
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: February 14, 2006
    Publication date: March 1, 2007
    Inventors: Claude Benedict, David Epstein, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas McCauley, James Rottman, Charles Wilson
  • Publication number: 20070009907
    Abstract: The invention discloses aptamers capable of binding to Immunoglobulin E (“IgE”) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE.
    Type: Application
    Filed: April 26, 2005
    Publication date: January 11, 2007
    Inventors: Paula Burmeister, Sharon Cload, John Diener, Anthony Keefe, Sara Keene, Markus Kurz, H.A. Lagasse, Harold Marsh, Pooja Sawhney, Chunhua Wang
  • Publication number: 20070009476
    Abstract: Materials and methods are provided for producing aptamer therapeutics having improved pharmacokinetic and pharmacodymanic properties, as well as increased target valency. The aptamers produced by the methods of the invention are useful as therapeutics for treating disease.
    Type: Application
    Filed: July 6, 2006
    Publication date: January 11, 2007
    Inventors: Charles Wilson, David Epstein, Jeffrey Kurz, Markus Kurz